Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder

Australasian Psychiatry

Volumn 16, Issue 6, 2008, Pages 457-459

  Kummer, Arthur ^a   Teixeira, Antonio ^a  

^a NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; METHYLPHENIDATE; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ACADEMIC ACHIEVEMENT; AGITATED DEPRESSION; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLUNTED AFFECT; CASE REPORT; CHILD; CLINICAL FEATURE; COMORBIDITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MOOD DISORDER;

ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; DRUG THERAPY, COMBINATION; HUMANS; LONG-TERM CARE; MALE; METHYLPHENIDATE; VALPROIC ACID;

EID: 84992828683     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1177/000486740801600602     Document Type: Article

References (14)

1. Biederman J Faraone S Mick E. Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity?. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 35: 997–1008.
2. West SA Strakowski SM Sax KW Minnery KL McElroy SL Keck PE Jr. The comorbidity of attention-deficit hyperactivity disorder in adolescent mania: potential diagnostic and treatment implications. Psychopharmacology Bulletin 1995; 31: 347–351.
3. Rappley MD. Clinical practice. Attention deficit-hyperactivity disorder. The New England Journal of Medicine 2005; 352: 165–173.
4. Goldberg JF Garno JL Leon AC Kocsis JH Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. The Journal of Clinical Psychiatry 1999; 60: 733–740.
5. Biederman J Mick E Prince J. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. Journal of Child and Adolescent Psychopharmacology 1999; 9: 247–256.
6. Carlson G Loney J Salisbury H Kramer J Arthur C. Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study. Journal of Child and Adolescent Psychopharmacology 2000; 10: 175–184.
7. Galanter CA Carlson GA Jensen PS. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. Journal of Child and Adolescent Psychopharmacology 2003; 13: 123–136.
8. Scheffer RE Kowatch RA Carmody T Rush AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. The American Journal of Psychiatry 2005; 162: 58–64.
9. Findling RL Short EJ McNamara NK. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2007; 46: 1153–1445.
10. Geller B Zimerman B Williams M. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. Journal of Child and Adolescent Psychopharmacology 2002; 12: 11–25.
11. Axelson D Birmaher B Strober M. Phenomenology of children and adolescents with bipolar spectrum disorders. Archives of General Psychiatry 2006; 63: 1139–1148.
12. Lewinsohn PM Klein DN Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 454–463.
13. Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. The American Journal of Psychiatry 2006; 163: 1149–1152.
14. El-Mallakh RS. An open study of methylphenidate in bipolar depression. Bipolar disorders 2000; 2: 56–59.